Wells Fargo
ARIA

Wells Fargo’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Wells Fargo’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,000
Closed -$2K – 6538
2014
Q4 		$2K Hold
10,000
– – ﹤0.01% 6049
2014
Q3 		$3K Buy
+10,000
New +$58.4K ﹤0.01% 5960

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Wells Fargo's ARIA Position: Q1 2017 in Review

Wells Fargo sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 178,632 shares — an estimated $2.22M sold.

Wells Fargo first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $8.8M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Wells Fargo reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Wells Fargo sold 178,632 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.22M.
  • Wells Fargo first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Wells Fargo's Ariad Pharmaceuticals Inc position peaked at $8.8M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Wells Fargo's 13F filing for Q1 2017, filed 28 Apr 2017.